| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 511 |
| 1 | IPILIMUMAB | 398 |
| 2 | CAPECITABINE | 397 |
| 3 | OXALIPLATIN | 351 |
| 4 | PREDNISOLONE | 322 |
| 5 | PREDNISOLONE ORAL | 322 |
| 6 | PREDNISOLONE ORAL SOLUTION | 322 |
| 7 | DEXAMETHASONE | 296 |
| 8 | DEXAMETHASONE 1.5 MG | 296 |
| 9 | CARBOPLATIN | 281 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MATICO, SARSAPARILLA (SMILAX REGELII), THUJA OCCIDENTALIS, UNCARIA TOMENTOSA, PHYLLANTHUS NIRURI, POLYGONUM CUSPIDATUM | 3 | 0.0417 |
| 1 | TREMELIMUMAB | 62 | 0.0140 |
| 2 | IPILIMUMAB | 398 | 0.0091 |
| 3 | TREOSULFAN | 25 | 0.0091 |
| 4 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 22 | 0.0090 |
| 5 | MEPIVACAINE HYDROCHLORIDE | 10 | 0.0086 |
| 6 | POTASSIUM BICARBONATE | 6 | 0.0083 |
| 7 | LEVOLEUCOVORIN INJECTION | 24 | 0.0078 |
| 8 | CILTACABTAGENE AUTOLEUCEL | 51 | 0.0078 |
| 9 | PALIFERMIN | 3 | 0.0077 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 954 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 852 |
| 2 | Platinum-based Drug [EPC] | 767 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 511 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 457 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 457 |
| 6 | Microtubule Inhibitor [EPC] | 348 |
| 7 | Proton Pump Inhibitor [EPC] | 338 |
| 8 | Alkylating Drug [EPC] | 319 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 264 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Macrolide Antibacterial [EPC] | 12 | 0.0119 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 457 | 0.0095 |
| 2 | Anthracycline Topoisomerase Inhibitor [EPC] | 22 | 0.0090 |
| 3 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 4 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 3 | 0.0077 |
| 5 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 8 | 0.0052 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 511 | 0.0052 |
| 7 | Carnitine Analog [EPC] | 16 | 0.0043 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 83 | 0.0038 |
| 9 | CD123 Interaction [EPC] | 2 | 0.0037 |